<DOC>
	<DOCNO>NCT00752128</DOCNO>
	<brief_summary>The primary objective RESOLUTE international registry document safety overall clinical performance Resolute Zotarolimus-Eluting Coronary Stent System 'real-world ' patient population require stent implantation .</brief_summary>
	<brief_title>RESOLUTE International Registry : Evaluation Resolute Zotarolimus-Eluting Stent System 'Real-World ' Patient Population</brief_title>
	<detailed_description>As part broader clinical program Resolute stent , RESOLUTE International registry expand experience understanding device performance 'real-world ' setting . The registry intend enroll patient large number center commercial usage condition , aim reflect 'real-world ' usage much possible .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Minimum legal age ( 18 ) Acceptable candidate treatment drugeluting stent accordance applicable guideline Patient consent participate authorize write collection release medical information Elective use Endeavor Resolute stent Pregnancy High probability nonadherence followup requirement ( due social , psychological medical reason ) Currently participate another trial prevent routine hospital treatment Previous enrollment RESOLUTE International registry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Drug Eluting Stent</keyword>
	<keyword>Interventional Cardiology</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>